Intersection of MicroRNA and gene regulatory networks and their implication in cancer

Current Pharmaceutical Biotechnology

Volumn 15, Issue 5, 2014, Pages 445-454

  Yousef, Malik ^a   Trinh, Hung V ^b   Allmer, Jens ^c  

^a Sakhnin College for Teacher Education   (Israel)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c IZMIR INSTITUTE OF TECHNOLOGY   (Turkey)

Author keywords

Invasion; Metastasis; microRNA; Network; Pathway; Petri nets; Reconstruction; Regulation; Tumor suppression

Indexed keywords

BIM PROTEIN; JANUS KINASE 2; MICRORNA; MICRORNA 107; MICRORNA 10B; MICRORNA 143; MICRORNA 151; MICRORNA 155; MICRORNA 15A; MICRORNA 16; MICRORNA 17; MICRORNA 21; MICRORNA 29; MICRORNA 373; MICRORNA 375; MICRORNA 520; MICRORNA 9; MICRORNA 92; PHOSPHATIDYLINOSITOL 3, 4, 5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P21; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN;

ARTICLE; CANCER CELL; CANCER INHIBITION; CARCINOGENESIS; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; DOWN REGULATION; GENE CONTROL; GENE EXPRESSION; HOMEOSTASIS; HUMAN; MATHEMATICAL MODEL; METASTASIS; NEOPLASM; NONHUMAN; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TUMOR INVASION; UPREGULATION; ANIMAL; GENE REGULATORY NETWORK; GENETICS; METABOLISM;

ANIMALS; GENE REGULATORY NETWORKS; HUMANS; MICRORNAS; NEOPLASMS;

EID: 84907165143     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/1389201015666140519120855     Document Type: Article

References (104)

1. Ørom, U. A.; Nielsen, F. C.; Lund, A. H. MicroRNA-10a binds the 5’UTR of ribosomal protein mRNAs and enhances their translation. Mol. Cell, 2008, 30(4), 460-471.
2. Vasudevan, S. Posttranscriptional upregulation by microRNAs. Wiley Interdiscip. Rev. RNA, 2011, 3(3), 311-330.
3. Huang, V.; Place, R. F.; Portnoy, V.; Wang, J.; Qi, Z.; Jia, Z.; Yu, A.; Shuman, M.; Yu, J.; Li, L. C. Upregulation of Cyclin B1 by miRNA and its implications in cancer. Nucleic Acids Res., 2012, 40(4), 1695-1707.
4. Vasudevan, S.; Tong, Y.; Steitz, J. A. Switching from repression to activation: microRNAs can up-regulate translation. Science, 2007, 318(5858), 1931-1934.
5. Mayr, M.; Zampetaki, A.; Willeit, P.; Willeit, J.; Kiechl, S. MicroRNAs within the continuum of postgenomics biomarker discovery. Arterioscler. Thromb. Vasc. Biol., 2013, 33(2), 206-214.
6. Barrett, L. W.; Fletcher, S.; Wilton, S. D. Regulation of eukaryotic gene expression by the untranslated gene regions and other noncoding elements. Cell. Mol. Life Sci., 2012, 69(21), 3613-3634.
7. Crick, F. Central dogma of molecular biology. Nature, 1970, 227(5258), 561-3.
8. Wu, J. Y.; Tang, H.; Havlioglu, N. Alternative pre-mRNA splicing and regulation of programmed cell death. Prog. Mol. Subcell. Biol., 2003, 31(2), 153-85.
9. Tanabe, M.; Kanehisa, M. Using the KEGG database resource. In: Curr. Protoc. Bioinformatics, 2012, vol. Chapter 1, p. Unit 1. 12.
10. Kanehisa, M.; Goto, S.; Sato, Y.; Furumichi, M.; Tanabe, M. KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res., 2012, 40(Database issue), D109-14.
11. D’Eustachio, P. Reactome knowledgebase of human biological pathways and processes. Methods Mol. Biol., 2011, 694, 49-61.
12. Copeland, W. B.; Bartley, B. A.; Chandran, D.; Galdzicki, M.; Kim, K. H.; Sleight, S. C.; Maranas, C. D.; Sauro, H. M. Computational tools for metabolic engineering. Metab. Eng., 2012, 14(3), 270-80.
13. Rohn, H.; Junker, A.; Hartmann, A.; Grafahrend-Belau, E.; Treutler, H.; Klapperstück, M.; Czauderna, T.; Klukas, C.; Schreiber, F. VANTED v2: A framework for systems biology applications. BMC Syst. Biol., 2012, 6(1), 139.
14. Smoot, M. E.; Ono, K.; Ruscheinski, J.; Wang, P.-L.; Ideker, T. Cytoscape 2. 8: new features for data integration and network visualization. Bioinformatics, 2011, 27(3), 431-432.
15. Schlitt, T.; Brazma, A. Current approaches to gene regulatory network modelling. BMC Bioinformatics, 2007, 8(Suppl 6), S9.
16. Geekiyanage, H.; Jicha, G. A.; Nelson, P. T.; Chan, C. Blood serum miRNA: non-invasive biomarkers for Alzheimer’s disease. Exp. Neurol., 2012, 235(2), 491-496.
17. Wang, F.; Sun, G.-P.; Zou, Y.-F.; Hao, J.-Q.; Zhong, F.; Ren, W.-J. MicroRNAs as promising biomarkers for gastric cancer. Cancer Biomark., 2012, 11(6), 259-267.
18. Satoh, J.-I. Molecular network analysis of human microRNA targetome: from cancers to Alzheimer’s disease. Bio Data Min., 2012, 5(1), 17.
19. Emmrich, S.; Pützer, B. M. Checks and balances: E2F-microRNA crosstalk in cancer control. Cell Cycle, 2010, 9(13), 2555-2567.
20. Zhang, S.; Li, Q.; Liu, J.; Zhou, X. J. A novel computational framework for simultaneous integration of multiple types of genomic data to identify microRNA-gene regulatory modules. Bioinformatics, 2011, 27(13), i401-409.
21. Kent, O. A.; Mendell, J. T. A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes. Oncogene, 2006, 25(46), 6188-6196.
22. Garzon, R.; Calin, G. A.; Croce, C. M. MicroRNAs in Cancer. Annu. Rev. Med., 2009, 60, 167-179.
23. Calin, G. A.; Dumitru, C. D.; Shimizu, M.; Bichi, R.; Zupo, S.; Noch, E.; Aldler, H.; Rattan, S.; Keating, M.; Rai, K.; Rassenti, L.; Kipps, T.; Negrini, M.; Bullrich, F.; Croce, C. M. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. USA, 2002, 99(24), 15524-15529.
24. Nakamura, T.; Canaani, E.; Croce, C. M. Oncogenic All1 fusion proteins target Drosha-mediated microRNA processing. Proc. Natl. Acad. Sci. USA, 2007, 104(26), 10980-10985.
25. Saito, Y.; Liang, G.; Egger, G.; Friedman, J. M.; Chuang, J. C.; Coetzee, G. A.; Jones, P. A. Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatinmodifying drugs in human cancer cells. Cancer Cell, 2006, 9(6), 435-443.
26. Calin, G. A.; Ferracin, M.; Cimmino, A.; Di Leva, G.; Shimizu, M.; Wojcik, S. E.; Iorio, M. V.; Visone, R.; Sever, N. I.; Fabbri, M.; Iuliano, R.; Palumbo, T.; Pichiorri, F.; Roldo, C.; Garzon, R.; Sevignani, C.; Rassenti, L.; Alder, H.; Volinia, S.; Liu, C. G.; Kipps, T. J.; Negrini, M.; Croce, C. M. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N. Engl. J. Med., 2005, 353(17), 1793-1801.
27. Cimmino, A.; Calin, G. A.; Fabbri, M.; Iorio, M. V.; Ferracin, M.; Shimizu, M.; Wojcik, S. E.; Aqeilan, R. I.; Zupo, S.; Dono, M.; Rassenti, L.; Alder, H.; Volinia, S.; Liu, C. G.; Kipps, T. J.; Negrini, M.; Croce, C. M. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc. Natl. Acad. Sci. USA, 2005, 102(39), 3944-13949.
28. Raveche, E. S.; Salerno, E.; Scaglione, B. J.; Manohar, V.; Abbasi, F.; Lin, Y. C.; Fredrickson, T.; Landgraf, P.; Ramachandra, S.; Huppi, K.; Toro, J. R.; Zenger, V. E.; Metcalf, R. A.; Marti, G. E.; Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice. Blood, 2007, 109(12), 5079-5086.
29. Iorio, M. V.; Ferracin, M.; Liu, C. G.; Veronese, A.; Spizzo, R.; Sabbioni, S.; Magri, E.; Pedriali, M.; Fabbri, M.; Campiglio, M.; Menard, S.; Palazzo, J. P.; Rosenberg, A.; Musiani, P.; Volinia, S.; Nenci, I.; Calin, G. A.; Querzoli, P.; Negrini, M.; Croce, C. M. MicroRNA gene expression deregulation in human breast cancer. Cancer Res., 2005, 65(16), 7065-7070.
30. Johnson, S. M.; Grosshans, H.; Shingara, J.; Byrom, M.; Jarvis, R.; Cheng, A.; Labourier, E.; Reinert, K. L.; Brown, D.; Slack, F. J. RAS is regulated by the let-7 microRNA family. Cell, 2005, 120(5), 635-647.
31. Yanaihara, N.; Caplen, N.; Bowman, E.; Seike, M.; Kumamoto, K.; Yi, M.; Stephens, R. M.; Okamoto, A.; Yokota, J.; Tanaka, T.; Calin, G. A.; Liu, C. G.; Croce, C. M.; Harris, C. C. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell, 2006, 9(3), 189-198.
32. Akao, Y.; Nakagawa, Y.; Naoe, T. let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. Biol. Pharm. Bull., 2006, 29(5), 903-906.
33. Lee, Y. S.; Dutta, A. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev., 2007, 21(9), 1025-1030.
34. Sampson, V. B.; Rong, N. H.; Han, J.; Yang, Q.; Aris, V.; Soteropoulos, P.; Petrelli, N. J.; Dunn, S. P.; Krueger, L. J. MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. Cancer Res., 2007, 67(20), 9762-9770.
35. Pedersen-Bjergaard, J.; Pedersen, M.; Roulston, D.; Philip, P. Different genetic pathways in leukemogenesis for patients presenting with therapy-related myelodysplasia and therapy-related acute myeloid leukemia. Blood, 1995, 86(9), 3542-3552.
36. Mott, J. L.; Kobayashi, S.; Bronk, S. F.; Gores, G. J. mir-29 regulates Mcl-1 protein expression and apoptosis. Oncogene, 2007, 26(42), 6133-6140.
37. Pekarsky, Y.; Santanam, U.; Cimmino, A.; Palamarchuk, A.; Efanov, A.; Maximov, V.; Volinia, S.; Alder, H.; Liu, C. G.; Rassenti, L.; Calin, G. A.; Hagan, J. P.; Kipps, T.; Croce, C. M. Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. Cancer Res., 2006, 66(24), 11590-11593.
38. He, L.; Thomson, J. M.; Hemann, M. T.; Hernando-Monge, E.; Mu, D.; Goodson, S.; Powers, S.; Cordon-Cardo, C.; Lowe, S. W.; Hannon, G. J.; Hammond, S. M. A microRNA polycistron as a potential human oncogene. Nature, 2005, 435(7043), 828-833.
39. Olive, V.; Bennett, M. J.; Walker, J. C.; Ma, C.; Jiang, I.; Cordon-Cardo, C.; Li, Q. J; Lowe, S. W.; Hannon, G. J.; He, L. miR-19 is a key oncogenic component of mir-17-92. Genes Dev., 2009, 23(24), 2839-2849.
40. Hong, L.; Lai, M.; Chen, M.; Xie, C.; Liao, R.; Kang, Y. J.; Xiao, C.; Hu, W. Y.; Han, J.; Sun, P. The miR-17-92 cluster of microRNAs confers tumorigenicity by inhibiting oncogene-induced senescence. Cancer Res., 2010, 70(21), 8547-8557.
41. Coller, H. A.; Forman, J. J.; Legesse-Miller, A. ’Myc’ed messages’: myc induces transcription of E2F1 while inhibiting its translation via a microRNA polycistron. PLoS Genet., 2007, 3(8), e146.
42. Hossain, A.; Kuo, M. T.; Saunders, G. F. Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA. Mol. Cell Biol., 2006, 26(21), 8191-8201.
43. Chan, J. A.; Krichevsky, A. M.; Kosik, K. S. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res., 2005, 65(14), 6029-6033.
44. Corsten, M. F.; Miranda, R.; Kasmieh, R.; Krichevsky, A. M.; Weissleder, R.; Shah, K. MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas. Cancer Res., 2007, 67(19), 8994-9000.
45. Papagiannakopoulos, T.; Shapiro, A.; Kosik, K. S. MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Cancer Res., 2008, 68(19), 8164-8172.
46. Yao, Q.; Xu, H.; Zhang, Q. Q.; Zhou, H.; Qu, L. H. MicroRNA-21 promotes cell proliferation and down-regulates the expression of programmed cell death 4 (PDCD4) in HeLa cervical carcinoma cells. Biochem. Biophys. Res. Commun., 2009, 388(3), 539-542.
47. Frankel, L. B.; Christoffersen, N. R.; Jacobsen, A.; Lindow, M.; Krogh, A.; Lund, A. H. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J. Biol. Chem., 2008, 283(2), 1026-1033.
48. Becker B. L. E.; Li, Y. Apoptosis and the target genes of miR-21. Chin. J. Cancer., 2011, 30(6), 10.
49. Esquela-Kerscher, A.; Slack, F. J. Oncomirs-microRNAs with a role in cancer. Nat. Rev. Cancer, 2006, 6(4), 259-269.
50. Eis, P. S.; Tam, W.; Sun, L.; Chadburn, A.; Li, Z.; Gomez, M. F.; Lund, E.; Dahlberg, J. E. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc. Natl. Acad. Sci. USA, 2005, 102(10), 3627-3632.
51. Costinean, S.; Sandhu, S. K.; Pedersen, I. M.; Tili, E.; Trotta, R.; Perrotti, D.; Ciarlariello, D.; Neviani, P.; Harb, J.; Kauffman, L. R.; Shidham, A.; Croce, C. M. Src homology 2 domain-containing inositol-5-phosphatase and CCAAT enhancer-binding protein beta are targeted by miR-155 in B cells of Emicro-MiR-155 transgenic mice. Blood, 2009, 114(7), 1374-1382.
52. Chen, J.; Wang, B. C.; Tang, J. H. Clinical significance of microRNA-155 expression in human breast cancer. J. Surg. Oncol., 2012, 106(3), 260-266.
53. Davey, G. M.; Heath, W. R.; Starr, R. SOCS1: A potent and multifaceted regulator of cytokines and cell-mediated inflammation. Tissue Antigens, 2006, 67(1), 1-9.
54. Jiang, S.; Zhang, H. W.; Lu, M. H.; He, X. H.; Li, Y.; Gu, H.; Liu, M. F.; Wang, E. D. MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene. Cancer Res., 2010, 70(8), 3119-3127.
55. Gironella, M.; Seux, M.; Xie, M. J.; Cano, C.; Tomasini, R.; Gommeaux, J.; Garcia, S.; Nowak, J.; Yeung, M. L.; Jeang, K. T.; Chaix, A.; Fazli, L.; Motoo, Y.; Wang, Q.; Rocchi, P.; Russo, A.; Gleave, M.; Dagorn, J. C.; Iovanna, J. L.; Carrier, A.; Pebusque, M. J.; Dusetti, N. J. Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development. Proc. Natl. Acad. Sci. USA, 2007, 104(41), 16170-16175.
56. Greither, T.; Grochola, L. F.; Udelnow, A.; Lautenschlager, C.; Wurl, P.; Taubert, H. Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival. Int. J. Cancer, 2010, 126(1), 73-80.
57. Nikiforova, M. N.; Tseng, G. C.; Steward, D.; Diorio, D.; Nikiforov, Y. E. MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility. J. Clin. Endocrinol. Metab., 2008, 93(5), 1600-1608.
58. Ma, L.; Weinberg, R. A. Micromanagers of malignancy: Role of microRNAs in regulating metastasis. Trends Genet., 2008, 24(9), 448-456.
59. Nicoloso, M. S.; Spizzo, R.; Shimizu, M.; Rossi, S.; Calin, G. A. MicroRNAs-the micro steering wheel of tumour metastases. Nat. Rev. Cancer, 2009, 9(4), 293-302.
60. Ma, L.; Teruya-Feldstein, J.; Weinberg, R. A. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature, 2007, 449(7163), 682-688.
61. Senyuk, V.; Zhang, Y.; Liu, Y.; Ming, M.; Premanand, K.; Zhou, L.; Chen, P.; Chen, J.; Rowley, J. D.; Nucifora, G.; Qian, Z. Critical role of miR-9 in myelopoiesis and EVI1-induced leukemogenesis. Proc. Natl. Acad. Sci. USA, 2013, 110(14), 5594-5599.
62. Ma, L.; Young, J.; Prabhala, H.; Pan, E.; Mestdagh, P.; Muth, D.; Teruya-Feldstein, J.; Reinhardt, F.; Onder, T. T.; Valastyan, S.; Westermann, F.; Speleman, F.; Vandesompele, J.; Weinberg, R. A. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat. Cell Biol., 2010, 12(3), 247-256.
63. Hildebrandt, M. A.; Gu, J.; Lin, J.; Ye, Y.; Tan, W.; Tamboli, P.; C.; Wood, G.; Wu, X. Hsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinoma. Oncogene, 2010, 29(42), 5724-5728.
64. Lujambio, A.; Calin, G. A.; Villanueva, A.; Ropero, S.; Sanchez-Cespedes, M.; Blanco, D.; Montuenga, L. M.; Rossi, S.; Nicoloso, M. S.; Faller, W. J.; Gallagher, W. M.; Eccles, S. A.; Croce, C. M.; Esteller, M. A microRNA DNA methylation signature for human cancer metastasis. Proc. Natl. Acad. Sci. USA, 2008, 105(36), 13556-13561.
65. Tan, H. X.; Wang, Q.; Chen, L. Z.; Huang, X. H.; Chen, J. S.; Fu, X. H.; Cao, L. Q.; Chen, X. L.; Li, W.; Zhang, L. J. MicroRNA-9 reduces cell invasion and E-cadherin secretion in SK-Hep-1 cell. Med. Oncol., 2009, 27(3), 654-660.
66. Nass, D.; Rosenwald, S.; Meiri, E.; Gilad, S.; Tabibian-Keissar, H.; A. Schlosberg, H. Kuker, N. Sion-Vardy, A. Tobar, O. Kharenko, Sitbon, E.; Lithwick Y. G.; Elyakim, E.; Cholakh, H.; Gibori, H.; Spector, Y.; Bentwich, Z.; Barshack, I.; Rosenfeld, N. MiR-92b and miR-9/9* are specifically expressed in brain primary tumors and can be used to differentiate primary from metastatic brain tumors. Brain Pathol., 2009, 19(3), 375-383.
67. Zhuang, G.; Wu, X.; Jiang, Z.; Kasman, I.; Yao, J.; Guan, Y.; Oeh, J.; Modrusan, Z.; Bais, C.; Sampath, D.; Ferrara, N. Tumoursecreted miR-9 promotes endothelial cell migration and angiogenesis by activating the JAK-STAT pathway. EMBO J., 2012, 31(17), 3513-3523.
68. Baffa, R.; Fassan, M.; Volinia, S.; O’Hara, B.; Liu, C. G.; Palazzo, J. P.; Gardiman, M.; Rugge, M.; Gomella, L. G.; Croce, C. M.; Rosenberg, A. MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets. J. Pathol., 2009, 219(2), 214-221.
69. Bloomston, M.; Frankel, W. L.; Petrocca, F.; Volinia, S.; Alder, H.; Hagan, J. P.; Liu, C. G.; Bhatt, D.; Taccioli, C.; Croce, C. M. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA, 2007, 297(17), 1901-1908.
70. Chai, G.; Liu, N.; Ma, J.; Li, H.; Oblinger, J. L.; Prahalad, A. K.; Gong, M.; Chang, L. S.; Wallace, M.; Muir, D.; Guha, A.; Phipps, R. J.; Hock, J. M.; Yu, X. MicroRNA-10b regulates tumorigenesis in neurofibromatosis type 1. Cancer Sci., 2010, 101(9), 1997-2004.
71. Tian, Y.; Luo, A.; Cai, Y.; Su, Q.; Ding, F.; Chen, H.; Liu; Z. MicroRNA-10b promotes migration and invasion through KLF4 in human esophageal cancer cell lines. J. Biol. Chem., 2010, 285(11), 7986-7994.
72. Li, G.; Wu, Z.; Peng, Y.; Liu, X.; Lu, J.; Wang, L.; Pan, Q.; He, M. L.; Li, X. P. MicroRNA-10b induced by Epstein-Barr virusencoded latent membrane protein-1 promotes the metastasis of human nasopharyngeal carcinoma cells. Cancer Lett., 2010, 299 (1), 29-36.
73. Yamakuchi, M.; Lotterman, C. D.; Bao, C.; Hruban, R. H.; Karim, B.; Mendell, J. T.; Huso, D.; Lowenstein, C. J. P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis. Proc. Natl. Acad. Sci. USA, 2010, 107(14), 6334-6339.
74. Chen, H. Y.; Lin, Y. M.; Chung, H. C.; Lang, Y. D.; Lin, C. J.; Huang, J.; Wang, W. C.; Lin, F. M.; Chen, Z.; Huang, H. D.; Shyy, J. Y.; Liang, J. T.; Chen, R. H. miR-103/107 promote metastasis of colorectal cancer by targeting the metastasis suppressors DAPK and KLF4. Cancer Res., 2012, 72(14), 3631-3641.
75. Martello, G.; Rosato, A.; Ferrari, F.; Manfrin, A.; Cordenonsi, M.; Dupont, S.; Enzo, E.; Guzzardo, V.; Rondina, M.; Spruce, T.; Parenti, A. R.; Daidone, M. G.; Bicciato, S.; Piccolo, S. A MicroRNA targeting dicer for metastasis control. Cell, 2010, 141(7), 1195-1207.
76. Chen, P. S.; Su, J. L.; Cha, S. T.; Tarn, W. Y.; Wang, M. Y.; Hsu, H. C.; Lin, M. T.; Chu, C. Y.; Hua, K. T.; Chen, C. N.; Kuo, T. C.; Chang, K. J.; Hsiao, M.; Chang, Y. W.; Chen, J. S.; Yang, P. C.; Kuo, M. L. miR-107 promotes tumor progression by targeting the let-7 microRNA in mice and humans. J. Clin. Invest., 2011, 121(9), 3442-3455.
77. Akao, Y.; Nakagawa, Y.; Kitade, Y.; Kinoshita, T.; Naoe, T. Downregulation of microRNAs-143 and-145 in B-cell malignancies. Cancer Sci., 2007, 98(12), 1914-1920.
78. Takagi, T.; Iio, A.; Nakagawa, Y.; Naoe, T.; Tanigawa, N.; Akao, Y. Decreased expression of microRNA-143 and-145 in human gastric cancers. Oncology, 2009, 77(1), 12-21.
79. Volinia, S.; Calin, G. A.; Liu, C. G.; Ambs, S.; Cimmino, A.; Petrocca, F.; Visone, R.; Iorio, M.; Roldo, C.; Ferracin, M.; Prueitt, R. L.; Yanaihara, N.; Lanza, G.; Scarpa, A.; Vecchione, A.; Negrini, M.; Harris, C. C.; Croce, C. M. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. USA, 2006, 103(7), 2257-2261.
80. Borralho, P. M.; Simoes, A. E.; Gomes, S. E.; Lima, R. T.; Carvalho, T.; Ferreira, D. M.; Vasconcelos, M. H.; Castro, R. E.; Rodrigues, C. M. miR-143 overexpression impairs growth of human colon carcinoma xenografts in mice with induction of apoptosis and inhibition of proliferation. PLoS One, 2011, 6(8), e23787.
81. Noguchi, S.; Mori, T.; Hoshino, Y.; Maruo, K.; Yamada, N.; Kitade, Y.; Naoe, T.; Akao, Y. MicroRNA-143 functions as a tumor suppressor in human bladder cancer T24 cells. Cancer Lett., 2011, 307(2), 211-220.
82. Boettger, T.; Beetz, N.; Kostin, S.; Schneider, J.; Kruger, M.; Hein, L.; Braun, T. Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster. J. Clin. Invest., 2009, 119(9), 2634-2647.
83. Chen, X.; Guo, X.; Zhang, H.; Xiang, Y.; Chen, J.; Yin, Y.; Cai, X.; Wang, K.; Wang, G.; Ba, Y.; Zhu, L.; Wang, J.; Yang, R.; Zhang, Y.; Ren, Z.; Zen, K.; Zhang, J.; Zhang, C. Y. Role of miR-143 targeting KRAS in colorectal tumorigenesis. Oncogene, 2009, 28(10), 1385-1392.
84. McLean, G. W.; Carragher, N. O.; Avizienyte, E.; Evans, J.; Brunton, V. G.; Frame, M. C. The role of focal-adhesion kinase in cancer-a new therapeutic opportunity. Nat. Rev. Cancer, 2005, 5(7), 505-515.
85. Ding, J.; Huang, S.; Wu, S.; Zhao, Y.; Liang, L.; Yan, M.; Ge, C.; Yao, J.; Chen, T.; Wan, D.; Wang, H.; Gu, J.; Yao, M.; Li, J.; Tu, H.; He, X. Gain of miR-151 on chromosome 8q24. 3 facilitates tumour cell migration and spreading through downregulating RhoGDIA. Nat. Cell Biol., 2010, 12(4), 390-399.
86. Ding, L.; Xu, Y.; Zhang, W.; Deng, Y.; Si, M.; Du, Y.; Yao, H.; Liu, X.; Ke, Y.; Si, J.; Zhou, T. MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2. Cell Res., 2010, 20(7), 784-793.
87. Jung, H. M.; Patel, R. S.; Phillips, B. L.; Wang, H.; Cohen, D. M.; Reinhold, W. C.; Chang, L. J.; Yang, L. J.; Chan, E. K. Tumor suppressor miR-375 regulates MYC expression via repression of CIP2A coding sequence through multiple miRNA-mRNA interaction. Mol. Biol. Cell, 2013, 24(11), 1638-1648.
88. Huang, Q.; Gumireddy, K.; Schrier, M.; le Sage, C.; Nagel, R.; Nair, S.; Egan, D. A.; Li, A.; Huang, G.; Klein-Szanto, A.; Gimotty, J.; Katsaros, P. A.; Coukos, D.; Zhang, G.; Pure, L. E.; Agami, R. The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat. Cell Biol., 2008, 10(2), 202-210.
89. Keklikoglou, I.; Koerner, C.; Schmidt, C.; Zhang, J. D.; Heckmann, D.; Shavinskaya, A.; Allgayer, H.; Guckel, B.; Fehm, T.; Schneeweiss, A.; Sahin, O.; Wiemann, S.; Tschulena, U. MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-kappaB and TGF-beta signaling pathways. Oncogene, 2012, 31(37), 4150-4163.
90. Reinhold, W. C.; Sunshine, M.; Liu, H.; Varma, S.; Kohn, K. W.; Morris, J.; Doroshow, J.; Pommier, Y. CellMiner: a web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set. Cancer Res., 2012, 72(14), 3499-3511.
91. Megraw, M.; Sethupathy, P.; Corda, B.; Hatzigeorgiou, A. G. miRGen: A database for the study of animal microRNA genomic organization and function. Nucleic Acids Res., 2007, 35(Database issue), D149-155.
92. Zhao, F.; Xuan, Z.; Liu, L.; Zhang, M. Q. TRED: A Transcriptional Regulatory Element Database and a platform for in silico gene regulation studies. Nucleic Acids Res., 2005, 33(Database issue), D103-7.
93. Yu, H.; Tu, K.; Wang, Y.-J.; Mao, J.-Z.; Xie, L.; Li, Y.-Y.; Li, Y.-X. Combinatorial network of transcriptional regulation and microRNA regulation in human cancer. BMC Syst. Biol., 2012, 6, 61.
94. Alon, U. Network motifs: theory and experimental approaches. Nat. Rev. Genet., 2007, 8(6), 450-461.
95. Li, J.; Hua, X.; Haubrock, M.; Wang, J.; Wingender, E. The architecture of the gene regulatory networks of different tissues. Bioinformatics, 2012, 28(18), i509-i514.
96. Luzi, E.; Marini, F.; Giusti, F.; Galli, G.; Cavalli, L.; Brandi, M. L. The negative feedback-loop between the oncomir Mir-24-1 and menin modulates the Men1 tumorigenesis by mimicking the ’Knudson’s second hit’. PLoS One, 2012, 7(6), e39767.
97. Herranz, H.; Cohen, S. M. MicroRNAs and gene regulatory networks: managing the impact of noise in biological systems. Genes Dev., 2010, 24(13), 1339-1344.
98. Wu, W. MicroRNA: potential targets for the development of novel drugs?, Drugs R. D., 2010, 10(1), 1-8.
99. Xiao, J.; Yang, B.; Lin, H.; Lu, Y.; Luo, X.; Wang, Z. Novel approaches for gene-specific interference via manipulating actions of microRNAs: Examination on the pacemaker channel genes HCN2 and HCN4. J. Cell. Physiol., 2007, 212(2), 285-292.
100. Lu, Y.; Xiao, J.; Lin, H.; Bai, Y.; Luo, X.; Wang, Z.; Yang, B. A single anti-microRNA antisense oligodeoxyribonucleotide (AMO) targeting multiple microRNAs offers an improved approach for microRNA interference. Nucleic Acids Res., 2009, 37(3), e24.
101. Gumireddy, K.; Young, D. D.; Xiong, X.; Hogenesch, J. B.; Huang, Q.; Deiters, A. Small-molecule inhibitors of microrna miR-21 function. Angew. Chem. Int. Ed. Engl., 2008, 47(39), 7482.
102. Miranda, K. C.; Huynh, T.; Tay, Y.; Ang, Y.-S.; Tam, W.-L.; Thomson, A. M.; Lim, B.; Rigoutsos, I. A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell, 2006, 126(6), 1203-1217.
103. Kitano, H. A robustness-based approach to systems-oriented drug design. Nat. Rev. Drug Discov., 2007, 6(3), 202-210.
104. Ebert, M. S.; Sharp P. A. Roles for microRNAs in conferring robustness to biological processes. Cell, 2012, 149(3), 515-524.